Technology | June 15, 2012

GE Healthcare Introduces Performance SPECT/CT System

Optima NM/CT640 offers CT image quality while keeping dose and ownership costs low

June 15, 2012 — At the 2012 Annual Meeting of the Society of Nuclear Medicine (SNM), GE Healthcare introduced the latest addition to its Nuclear Medicine 600 series with a new performance SPECT/CT (single photon emission computed tomography/computed tomography) system, the Optima NM/CT 640. The new system offers nuclear medicine physicians the optimal balance of image quality, patient dose efficiency and low total cost of ownership.

Based on the 600 series’ SPECT technology found in the Discovery NM 630, this system integrates the general-purpose camera with a newly developed 4-slice CT designed for hybrid rather than standalone CT use. The CT, available in 2.5 mm and 5 mm slice thicknesses to optimize dose and resolution required for particular procedures, offers clinicians confidence with routinely low CT dose at 1-2 mSv for a 40-cm abdomen CT scan.

The Optima NM/CT 640 can be fully upgraded on location from a Discovery NM 630 SPECT-only system, and may be upgraded in the future to a 16-slice Discovery NM/CT 670, expanding not only its clinical capability, but offering the potential for research use.

With its small footprint the Optima NM/CT 640 requires minimal renovation and installation costs. With the benefit of optimized CT power, shielding and control room requirements are often eliminated, saving as much as $100,000 compared to higher CT-powered systems.

“At GE Healthcare, we are dedicated to pushing nuclear medicine to its full potential and investing in its future,” said Nathan Hermony, general manager, nuclear medicine, GE Healthcare. “We’re focused on developing equipment that helps customers address the challenges they are confronted with every day: high image quality, low dose and short exam times. Adding the Optima NM/CT 640 to our portfolio helps us strengthen this position, allows customers to upgrade as their needs expand, and continues to benefit clinicians and their patients.”

Adding all the benefits of the Xeleris Workstation with the Evolution technology to the Optima NM/CT 640 reduces the tradeoffs that are often required between acquisition time, dose and image quality by allowing clinicians to feel confident in their diagnosis, reducing time or injected patient dose by up to 50 percent in most scanning procedures while still maintaining excellent image quality. The Xeleris Workstation — which integrates new and existing nuclear medicine equipment, including legacy GE and non-GE devices — is designed to provide consistent results and enhanced workflow. Xeleris can keep clinicians connected to images and applications from picturing archiving and communications systems (PACS) and PCs with their institution and remotely.

For more information: www.gehealthcare.com

Related Content

News | Business | September 19, 2017
September 19, 2017 — Invicro LLC, a provider of imaging services and software for research and drug development, anno
ScImage and Invia Partnership Announced
News | PACS | September 19, 2017
ScImage Inc. and Invia Imaging Solutions recently announced formation of a joint partnership at the American Society of...
Toshiba Highlights Latest CT Advancements at RSNA 2017
News | Computed Tomography (CT) | September 18, 2017
Toshiba Medical announced that it will display several new enhancements to its existing computed tomography (CT)...
Philips Launches CardioMD IV Cardiac SPECT Solution at ASNC 2017
Technology | SPECT Imaging | September 15, 2017
September 15, 2017 — Philips highlighted its newest solution for...
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Blue Earth Diagnostics Announcing Results of FALCON PET/CT Trial at ASTRO 2017
News | PET-CT | September 13, 2017
September 13, 2017 — Blue Earth Diagnostics announced the upcoming oral presentation of initial results from the FALC
FDG-PET/CT Predicts Melanoma Patients' Response to Immune Checkpoint Inhibitor Therapy
News | PET-CT | September 07, 2017
September 7, 2017 — Advanced melanoma has a poor prognosis, but immune checkpoint inhibitor therapy can be effective
German Team Optimizing Therapy Planning for Cancers of the Liver
News | Interventional Radiology | August 29, 2017
Radioembolization is a therapy method used for liver tumors that are uncurable with surgery or chemotherapy. Thorough...
Sponsored Content | Videos | Nuclear Imaging | August 24, 2017
Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and p
Overlay Init